NCT00565071

Brief Summary

The purpose of this study is to compare the cost-effectiveness of treating malaria based on three methods of diagnosis (rapid test, microscopy and presumptive diagnosis) among patients attending level three government health centres located in areas of low and high transmission intensities in Uganda. The study hypotheses are: in both low and high transmission areas, cost-effectiveness of malaria treatment with Artemether-Lumefantrine will be improved by the adoption of rapid diagnostic tests when compared with presumptive diagnosis or microscopy; and the difference between the cost-effectiveness of Artemether-Lumefantrine treatment following rapid diagnostic test or microscopy versus presumptive diagnosis will be greatest in low transmission areas.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102,087

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2006

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2006

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

November 28, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 29, 2007

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

March 28, 2012

Status Verified

March 1, 2012

Enrollment Period

5.4 years

First QC Date

November 28, 2007

Last Update Submit

March 27, 2012

Conditions

Keywords

Cost-effectivenessDiagnosisTreatmentMalaria

Outcome Measures

Primary Outcomes (1)

  • diagnostic test validity; unit cost per malaria case diagnosed and treated with Artemether-Lumefantrine; total savings associated with treatment of confirmed malaria cases; compliance with directives for use of rapid test or microscopy

    18 months

Secondary Outcomes (1)

  • unit cost of non-malaria febrile treatment; therapeutic behaviour in light of pressure to prescribe antimalarials

    18 months

Study Arms (3)

Field microscopy

OTHER

Field microscopy is the main method of malaria diagnosis

Device: Field microscopy and Paracheck Pf®

Paracheck Pf® device

OTHER

Paracheck Pf® device (Rapid Diagnostic Test) is the main method for malaria diagnosis

Device: Field microscopy and Paracheck Pf®

Presumptive diagnostic method

NO INTERVENTION

Interventions

Malaria diagnosis based on microscopy and or Paracheck Pf®. Artemether/Lumefantrine (20mg/120mg) is first-line drug in all arms

Field microscopyParacheck Pf® device

Eligibility Criteria

Age3 Months+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Suspected uncomplicated malaria infection
  • Consent to participate

You may not qualify if:

  • Pregnancy (policy recommends quinine for treatment of malaria in pregnancy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bushenyi and Iganga districts - Government Health Cetres level III

Bushenyi and Iganga, Uganda

RECRUITING

Related Publications (6)

  • Batwala V, Magnussen P, Nuwaha F. Challenges to implementation of artemisinin combination therapy policy in Uganda. Int Health. 2010 Dec;2(4):262-8. doi: 10.1016/j.inhe.2010.07.002.

  • Batwala V, Magnussen P, Mirembe J, Mulogo E, Nuwaha F. Timing of malaria messages for target audience on radio airwaves. Malar J. 2012 Aug 20;11:283. doi: 10.1186/1475-2875-11-283.

  • Batwala V, Magnussen P, Nuwaha F. Antibiotic use among patients with febrile illness in a low malaria endemicity setting in Uganda. Malar J. 2011 Dec 20;10:377. doi: 10.1186/1475-2875-10-377.

  • Batwala V, Magnussen P, Nuwaha F. Comparative feasibility of implementing rapid diagnostic test and microscopy for parasitological diagnosis of malaria in Uganda. Malar J. 2011 Dec 19;10:373. doi: 10.1186/1475-2875-10-373.

  • Batwala V, Magnussen P, Hansen KS, Nuwaha F. Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda. Malar J. 2011 Dec 19;10:372. doi: 10.1186/1475-2875-10-372.

  • Batwala V, Magnussen P, Nuwaha F. Are rapid diagnostic tests more accurate in diagnosis of plasmodium falciparum malaria compared to microscopy at rural health centres? Malar J. 2010 Dec 2;9:349. doi: 10.1186/1475-2875-9-349.

MeSH Terms

Conditions

FeverMalariaDisease

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsProtozoan InfectionsParasitic DiseasesInfectionsMosquito-Borne DiseasesVector Borne DiseasesPathologic Processes

Study Officials

  • Fred Nuwaha, MD, PhD

    Department of Disease Control and Environmental Health, Makerere Universtiy School of Public Health

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Fred Nuwaha, MD, PhD, Makerere University School of Public Health

Study Record Dates

First Submitted

November 28, 2007

First Posted

November 29, 2007

Study Start

October 1, 2006

Primary Completion

March 1, 2012

Study Completion

December 1, 2012

Last Updated

March 28, 2012

Record last verified: 2012-03

Locations